Clinical Trial Update: A Study of CCT301-59 CAR T Therapy in Adult Subjects With Recurrent or Refractory Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial of CCT301-59 CAR T therapy in adults with recurrent or refractory solid tumors has been terminated. The study included soft tissue sarcoma, gastri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Gastric Cancer
• Pancreatic Cancer
• Soft Tissue Sarcoma

Drugs mentioned

• CCT301-59 CAR T Therapy

Snippet

Sponsor: Shanghai PerHum Therapeutics Co., Ltd. | Conditions: Solid Tumor, Soft Tissue Sarcoma | Phase 1 | Status: TERMINATED